Yoko Inoue

2.0k total citations
76 papers, 1.5k citations indexed

About

Yoko Inoue is a scholar working on Molecular Biology, Cell Biology and Epidemiology. According to data from OpenAlex, Yoko Inoue has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Cell Biology and 8 papers in Epidemiology. Recurrent topics in Yoko Inoue's work include Proteoglycans and glycosaminoglycans research (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Long-Term Effects of COVID-19 (4 papers). Yoko Inoue is often cited by papers focused on Proteoglycans and glycosaminoglycans research (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Long-Term Effects of COVID-19 (4 papers). Yoko Inoue collaborates with scholars based in Japan, United States and China. Yoko Inoue's co-authors include Toshio Imai, Akiko Hamaguchi, Shuichi Fujikawa, Miyuki Nishimura, Yoshimasa Sakamoto, Tomoya Nakatani, Eri Mizuhara, Yasuko Minaki, Jun Takahashi and Minoru Kumai and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Chemistry.

In The Last Decade

Yoko Inoue

74 papers receiving 1.5k citations

Peers

Yoko Inoue
Comparison fields: 5 of 141
  • Molecular Biology 641
  • Cellular and Molecular Neuroscience 246
  • Oncology 182
  • Immunology 168
  • Cell Biology 145
Replace Jian Xu with:
Jian Xu China
Ming Fan China
Shuai Li China
Tingting Yu China
Andrea Pasini Italy
Jaron Liu Singapore
Yuichi Abe Japan
Tśuyoshi Soji Japan
Toru Nakamura Japan
Maria A. Mariggiò Italy
Jian Xu China View profile →
Citations per field, relative to Yoko Inoue
Yoko Inoue · 1×
Citations per year, relative to Yoko Inoue
Yoko Inoue · 1×

Countries citing papers authored by Yoko Inoue

Since Specialization
Citations

This map shows the geographic impact of Yoko Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Inoue more than expected).

Fields of papers citing papers by Yoko Inoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Inoue. The network helps show where Yoko Inoue may publish in the future.

Co-authorship network of co-authors of Yoko Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Inoue. A scholar is included among the top collaborators of Yoko Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Inoue. Yoko Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 7
2 3
3 11
4 12
5 10
6 2
7 25
8 1
9 20
10 3
11 8
12 9
13 6
14 5
15 4
16 2
17 15
18 2
19 2
20 9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026